Investment Thesis
Neuraxis is a pre-revenue/early-stage company burning significant cash with zero topline growth despite high gross margins, indicating fundamental business model execution challenges. While the balance sheet is fortress-like with low debt and excellent liquidity providing ~5-6 year runway, the company must demonstrate meaningful revenue acceleration and operating leverage to justify continued equity investment.
Strengths
- Exceptional balance sheet with only 0.03x debt-to-equity and $7.1M cash representing 81.6% of assets
- Outstanding liquidity with 2.89x current ratio and 2.81x quick ratio
- Healthy 86.4% gross margin indicates underlying product economics are viable if scaled
Risks
- Stagnant revenue of $1.6M with 0% YoY growth indicates market traction or adoption failures
- Operating expenses consuming 208% of gross profit, resulting in -108.3% operating margin
- Negative operating cash flow of -$1.2M annually with no path to profitability evident
- Company burning ~$1.3M in free cash flow annually despite strong cash balance
Key Metrics to Watch
- Revenue growth acceleration (critical - must exit 0% growth phase)
- Operating cash flow trend (must turn positive)
- Operating expense ratio relative to gross profit (must decrease from 208%)
Financial Metrics
Revenue
1.6M
Net Income
-1.8M
EPS (Diluted)
$-0.18
Free Cash Flow
-1.3M
Total Assets
8.7M
Cash
7.1M
Profitability Ratios
Gross Margin
86.4%
Operating Margin
-108.3%
Net Margin
-109.5%
ROE
-30.6%
ROA
-20.1%
FCF Margin
-78.4%
Balance Sheet & Liquidity
Current Ratio
2.89x
Quick Ratio
2.81x
Debt/Equity
0.03x
Debt/Assets
34.3%
Interest Coverage
-66.47x
Long-term Debt
166.1K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-13T08:59:36.568718 |
Data as of: 2026-03-31 |
Powered by Claude AI